Google launches $10 million REPLIQA program merging quantum computing with life sciences

Google has launched REPLIQA, a new $10 million research program that brings together its quantum computing and artificial intelligence teams with life-sciences researchers, with the goal of using quantum-enhanced simulation to study biological processes at the molecular level. The program is specifically targeting notoriously difficult problems such as protein folding — predicting the three-dimensional shapes that proteins fold into, which underpins much of modern drug discovery — and modeling how the human body metabolizes different drug compounds. Google says the initiative is a long-term bet rather than a near-term product push, with the company aiming for what it calls 'utility-scale quantum advantage' in life sciences sometime in the early 2030s, meaning a point at which quantum computers can solve real biological problems faster, cheaper or more accurately than classical supercomputers. The announcement reflects a broader trend of major technology companies pairing quantum computing research with AI and life sciences, on the theory that the fields are likely to advance together: AI models can help identify which biological problems are worth tackling with quantum methods, while quantum hardware may eventually unlock simulations that today's most powerful classical computers simply cannot run within a reasonable amount of time or cost.